DIVIDEND ANNOUNCEMENT: Biotechnology & Genome ETF/Invesco Exchange-Traded Fund Trust (NYSE:PBE) on 06/18/2026 declared a dividend of $0.8106 per share

Biotechnology & Genome ETF/Invesco Exchange-Traded Fund Trust (NYSE:PBE) on 06/18/2026 declared a dividend of $ 0.8106 per share payable on June 26, 2026 to shareholders of record as of June 22, 2026. Dividend amount recorded is an increase of $ 0.7282 from last dividend Paid.

Biotechnology & Genome ETF/Invesco Exchange-Traded Fund Trust (NYSE:PBE) has paid dividends since 2009, has a current dividend yield of 1.8356227875% and has increased its dividends for 2 successive years.

Biotechnology & Genome ETF/Invesco Exchange-Traded Fund Trust's market cap is $ 443,310,000 and has a PE ratio of 0.00. The stock price closed yesterday at $ 84.44 and has a 52 week low/high of $ 62.63 and $ 85.73.

PowerShares Dynamic Biotech & Genome Portfolio is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Index consists of stocks of 30 United States biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture, and marketing and distribution of various biotechnological products, services and processes. As of Apr 30 2013, the Fund's total assets were $157,068,804and the Fund's investments portfolio was valued at $155,655,581.

For more information on Biotechnology & Genome ETF/Invesco Exchange-Traded Fund Trust click here.